Current Neuro-Oncology

Volume 23 Number 15
15 August 2021

Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 15, 15 August

Aljabab S, Rana S, Maes S, O'Ryan-Blair A, Castro J, Zheng J, Halasz LM, Taddei PJ.
The Advantage of Proton Therapy in Hypothalamic-Pituitary Axis and Hippocampus Avoidance for Children with Medulloblastoma.
Int J Part Ther. 2021 Aug 2, 2021;8(3):43-54
. doi: 10.14338/IJPT-21-00001.1. PMID: 35127975. Observational study. ˍ

Ceravolo I, Barchetti G, Biraschi F, Gerace C, Pampana E, Pingi A, Stasolla A.
Early stage glioblastoma: retrospective multicentric analysis of clinical and radiological features.
Radiol Med. 2021 Aug 2, 2021;126(11):1468-1476
. doi: 10.1007/s11547-021-01401-4. PMID: 34338949. Observational study˰ ˍ

Banan R, Akbarian A, Samii M, Samii A, Bertalanffy H, Lehmann U, Hartmann C, Brüning R.
Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.
PLoS One. 2021 Aug 4, 2021;16(8):e0249647
. doi: 10.1371/journal.pone.0249647. PMID: 34347774. Observational study. ˍ

Mizumoto M, Liang HK, Oshiro Y, Matsuda M, Kohzuki H, Iizumi T, Numajiri H, Nakai K, Okumura T, Ishikawa E, Sakurai H.
Radiation Therapy for Grade 3 Gliomas: Correlation of MRI Findings With Prognosis.
Cureus. 2021 Aug 4, 2021;13(8):e16887
. doi: 10.7759/cureus.16887. PMID: 34513462. Observational study. ˍ

Su JM, Kilburn LB, Mansur DB, Krailo M, Buxton A, Adekunle A, Gajjar A, Adamson PC, Weigel B, Fox E, Blaney SM, Fouladi M.
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report.
Neuro Oncol. 2021 Aug 4, 2022 Apr;24(4):655-664
. doi: 10.1093/neuonc/noab188. PMID: 34347089. Interventional study. ˍ

Bagchi A, Beddows I, Cornelius A, Robinson GW, Jewell SD.
Rare cases of medulloblastoma with hypermutation.
Cancer Rep (Hoboken). 2021 Aug 5, 2022;5(5):e1521
. doi: 10.1002/cnr2.1521. PMID: 34351088. Observational study. ˍ

Mansfield AS, Hong DS, Hann CL, Farago AF, Beltran H, Waqar SN, Hendifar AE, Anthony LB, Taylor MH, Bryce AH, Tagawa ST, Lewis K, Niu J, Chung CH, Cleary JM, Rossi M, Ludwig C, Valenzuela R, Luo Y, Aggarwal R.
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors.
NPJ Precis Oncol. 2021 Aug 5, 2021;5(1):74
. doi: 10.1038/s41698-021-00214-y. PMID: 34354225. Interventional study. ˍ

Volpe S, Bondiau PY, Claude L, Claren A, Padovani L, AlGhamdi H, Duhil De Benaze G, Opitz L, Baudin G, Dejean C, Maneval D, Jereczek-Fossa BA, Doyen J.
Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.
Strahlenther Onkol. 2021 Aug 5, 2021;197(12):1113-1123
. doi: 10.1007/s00066-021-01828-8. PMID: 34351450. Observational study. ˍ

McCrea HJ, Ivanidze J, O'Connor A, Hersh EH, Boockvar JA, Gobin YP, Knopman J, Greenfield JP.
Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
J Neurosurg Pediatr. 2021 Aug 6, 2021;28(4):371-379
. doi: 10.3171/2021.3.PEDS20738. PMID: 34359048. Interventional study. ˍ

Fernández-de Thomas RJ, Pellot Cestero JE, Carballo Cuello CM, De Jesus O.
Unusual extracranial spread of glioblastoma.
BMJ Case Rep. 2021 Aug 10, 2021;14(8):e243909
. doi: 10.1136/bcr-2021-243909. PMID: 34376419. Case report. ˍ

Lombardi G, Del Bianco P, Brandes AA, Eoli M, Rudà R, Ibrahim T, Lolli I, Rizzato S, Daniele B, Pace A, Pasqualetti F, Caccesse M, Bergo E, Magni G, De Salvo GL, Zagonel V.
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial).
Eur J Cancer. 2021 Aug 10, 2021;155:179-190
. doi: 10.1016/j.ejca.2021.06.055. PMID: 34388515. Interventional study. ˍ


Jena A, Taneja S, Khan AA, Sogani SK.
Recurrent Glioma: Does Qualitative Simultaneous 18F-DOPA PET/mp-MRI Improve Diagnostic Workup? An Initial Experience.
Clin Nucl Med. 2021 Aug 11, 2021;46(9):703-709
. doi: 10.1097/RLU.0000000000003728. PMID: 34374678. Observational study˰ ˍ

Annavarapu S, Gogate A, Pham T, Davies K, Singh P, Robert N.
Treatment patterns and outcomes for patients with newly diagnosed glioblastoma multiforme: a retrospective cohort study.
CNS Oncol. 2021 Aug 11, 2021;10(3):CNS76
. doi: 10.2217/cns-2021-0007. PMID: 34378977. Observational study. ˍ

Jo J, Donahue J, Sarai G, Petroni G, Schiff D.
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Neuro Oncol. 2021 Aug 12, 2022;24(3):455-464
. doi: 10.1093/neuonc/noab198. PMID: 34383073. Observational study. ˍ

Sagberg LM, Jakola AS, Reinertsen I, Solheim O.
How well do neurosurgeons predict survival in patients with high-grade glioma?
Neurosurg Rev. 2021 Aug 12, 2022;45(1):865-872
. doi: 10.1007/s10143-021-01613-2. PMID: 34382108. Interventional study. ˍ

Li C, Li W, Dai S, Sharma A, Sharma HS, Wu Y.
Targeted therapy with anlotinib for a leptomeningeal spread recurrent glioblastoma patient.
Prog Brain Res. 2021 Aug 13, 2021;265:407-414
. doi: 10.1016/bs.pbr.2021.06.018. PMID: 34560927. Case report˰ ˍ

Yuan C, Yao Q, Cheng L, Zhang C, Ma L, Guan J, Jian F.
Prognostic factors and nomogram prediction of survival probability in primary spinal cord astrocytoma patients.
J Neurosurg Spine. 2021 Aug 13:1-12
. doi: 10.3171/2021.1.SPINE202017. PMID: 34388706. Observational study. ˍ


Wang GM, Cioffi G, Patil N, Waite KA, Lanese R, Ostrom Q, Kruchko C, Berens ME, Connor JR, Lathia JD, Rubin JB, Barnholtz-Sloan JS.
Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.
Neuro Oncol. 2021 Aug 13,
2022;24(2):302-310. doi: 10.1093/neuonc/noab199. PMID: 34387331. Observational study. ˍ

Quinones MC, Bélanger K, Lemieux Blanchard É, Lemieux B, Bahary JP, Masucci LG, Roberge D, Menard C, Lambert C, Berthelet F, Moumdjian R, Florescu M.
Adult Medulloblastoma Demographic, Tumor and Treatment Impact since 2006: A Canadian University Experience.
Curr Oncol. 2021 Aug 14, 2021;28(4):3104-3114
. doi: 10.3390/curroncol28040271. PMID: 34436037. Observational study. ˍ